Clinical TrialsSearch results
Number of results: 480
Recruiting
- A Randomized, Double-Blind, Phase III Study Comparing Investigational Drug HBI-8000 Combined With Nivolumab vs. Placebo with Nivolumab in Patients With Advanced Melanoma
- Unresectable or Metastatic Melanoma
- Ning John
- 2023-03-27
Recruiting
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Non-Small Cell Lung Cancer (NSCLC)
- Nakatani Iwami
- 2023-12-06
Recruiting
- A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
- Breast Cancer
- Inoguchi Akihiro
- 2023-01-22
Recruiting
- A study of dostarlimab in combination with carboplatin-paclitaxel in Japanese participants with primary advanced or recurrent endometrial cancer
- Endometrial Cancer
- Ishibashi Hideyasu
- 2024-03-28
Recruiting
- A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer
- Locally Advanced, Unresectable, or Metastatic Non -Small Cell Lung Cancer
- Tsumura Akari
- 2021-09-28
Recruiting
- A Study of Zipalertinib and Chemotherapy Compared With Chemotherapy Alone in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion
- Locally advanced or metastatic nonsquamous NSCLC harboring EGFR exon 20 insertion mutations
- Wacheck Volker
- 2023-09-12
Recruiting
- A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation
- Advanced/metastatic NSCLC with Exon 20 insertions and Uncommon/Single or Compound EGFR Mutations
- Wacheck Volker
- 2023-09-12
Recruiting
- A study on safety and efficacy of high-flow nasal cannula attachable hydrogen gas generator for ARDS
- Acute respiratory distress syndrome
- Nakao Atsunori
- 2022-04-12
Recruiting
- A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 in Participants With Relapsed or Refractory T-cell Lymphomas in Japan
- Relapsed or Refractory T-cell Lymphoma
- Hayakawa Jin
- 2023-09-27
Recruiting
- A Study to Compare the Efficacy and Safety of Ide-cel with LEN Maintenance Therapy Versus LEN Maintenance Therapy Alone in Adult Participants with NDMM Who Have Suboptimal Response After ASCT
- Multiple Myeloma
- Cook Mark
- 2023-12-24